<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">The ZIKV was first suspected to be in semen following case reports of travel-associated transmission to sexual partners in non-endemic areas.
 <xref rid="bib25" ref-type="bibr">
  <sup>25</sup>
 </xref> Since then, multiple studies have confirmed the presence of ZIKV RNA in semen by reverse transcription polymerase chain reaction (RT-PCR).
 <xref rid="bib26" ref-type="bibr">26</xref>, 
 <xref rid="bib27" ref-type="bibr">27</xref>, 
 <xref rid="bib28" ref-type="bibr">28</xref>, 
 <xref rid="bib29" ref-type="bibr">29</xref>, 
 <xref rid="bib30" ref-type="bibr">30</xref> A 2018 prospective study by Mead et al
 <xref rid="bib27" ref-type="bibr">
  <sup>27</sup>
 </xref> found that semen was positive with ZIKV in 33% of men, including 61% of those tested within 30 days of symptom onset. Infectious ZIKV was detected in 15% of RNA-positive semen samples collected within 30 days of symptom onset, but 0% of samples obtained after 30 days of disease onset were infectious. Evidence from Joguet et al
 <xref rid="bib28" ref-type="bibr">
  <sup>28</sup>
 </xref> and Matusali et al
 <xref rid="bib31" ref-type="bibr">
  <sup>31</sup>
 </xref> suggests that the virus is particularly infectious to spermatocytes, but Matusali et al
 <xref rid="bib31" ref-type="bibr">
  <sup>31</sup>
 </xref> also demonstrated in testis explants that the virus can infect Sertoli cells and release infectious particles on the adluminal side of the BTB.
</p>
